C3 Polymorphisms and allograft outcome in renal transplantation

New England Journal of Medicine

Volumn 360, Issue 9, 2009, Pages 874-880

  Varagunam, Mira ^a   Yaqoob, Muhammad M ^a,c   Döhler, Bernd ^b   Opelz, Gerhard ^b  

^a NATIONAL HEALTH SERVICE   (United Kingdom)

^b UNIVERSITY OF HEIDELBERG   (Germany)

^c ROYAL LONDON HOSPITAL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

COMPLEMENT COMPONENT C3; CREATININE; DNA; C3 PROTEIN, HUMAN;

ACUTE GRAFT REJECTION; ADULT; ALLELE; ALLOGRAFT; ARTICLE; CHRONIC ALLOGRAFT NEPHROPATHY; COMPLEMENT ACTIVATION; CONTROLLED STUDY; CREATININE BLOOD LEVEL; DISEASE ASSOCIATION; DNA POLYMORPHISM; FEMALE; GENOTYPE; GRAFT SURVIVAL; HUMAN; KIDNEY DONOR; KIDNEY TRANSPLANTATION; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; RECIPIENT; SURVIVAL RATE; TREATMENT OUTCOME; ALLOTRANSPLANTATION; BLOOD; GENETIC POLYMORPHISM; GENETICS; GRAFT REJECTION; PROPORTIONAL HAZARDS MODEL; RISK FACTOR; SURVIVAL;

ADULT; COMPLEMENT C3; CREATININE; FEMALE; GENOTYPE; GRAFT REJECTION; HUMANS; KIDNEY TRANSPLANTATION; MALE; POLYMORPHISM, GENETIC; PROPORTIONAL HAZARDS MODELS; RISK FACTORS; SURVIVAL ANALYSIS; TRANSPLANTATION, HOMOLOGOUS; TREATMENT OUTCOME;

EID: 61449248282     PISSN: 00284793     EISSN: 15334406     Source Type: Journal    
DOI: 10.1056/NEJMoa0801861     Document Type: Article

References (18)

1. Yates PJ, Nicolson ML. The aetiology and pathogenesis of chronic allograft nephropathy. Transpl Immunol 2006;16:148-57.
2. Sacks SH, Chowdhury P, Zhou W. Role of the complement system in rejection. Curr Opin Immunol 2003;15:487-92.
3. Pratt JR, Basheer SA, Sacks SH. Local synthesis of complement component C3 regulates acute renal transplant rejection. Nat Med 2002;8:582-7.
4. Teisberg P. High voltage agarose gel electrophoresis in the study of C3 polymorphism. Vox Sang 1970;19:47-56.
5. Rambausek M, van den Wall Bake AW, Schumacher-Ach R, et al. Genetic polymorphism of C3 and Bf in IgA nephropathy. Nephrol Dial Transplant 1987;2:208- 11.
6. Yates JR, Sepp T, Matharu BK. Complement C3 variant and the risk of age- related macular degeneration. N Engl J Med 2007;357:553-61.
7. Finn JE, Zhang L, Agrawal S, Jayne DR, Oliveira DB, Mathieson PW. Molecular analysis of C3 allotypes in patients with systemic vasculitis. Nephrol Dial Transplant 1994;9:1564-7.
8. Poznansky MC, Clissod PM, Lach- mann PJ. The difference between human C3F and C3S results from a single amino acid change from an asparagine to an aspartate residue at position 1216 on the alpha-chain of the complement component, C3. J Immunol 1989;143:1254-8. [Erratum, J Immunol 1989;143:3860-1.]
9. Andrews PA, Finn JE, Mathieson PW, Sacks SH. Molecular analysis of C3 allotypes related to transplant outcome in human renal allografts. Transplantation 1995; 60:1342-6.
10. Brown KM, Kondeatis E, Vaughan RW, et al. Influence of donor C3 allotype on late renal-transplantation outcome. N Engl J Med 2006;354:2014-23.
11. Heinold A, Opelz G, Scherer S, et al. Role of minor histocompatibility antigens in renal transplantation. Am J Transplant 2008;8:95-102.
12. Feucht HE. Complement C4d in graft capillaries - the missing link in the recognition of humoral alloreactivity. Am J Transplant 2003;3:646-52.
13. Andrews PA, Finn JE, Lloyd CM, Zhou W, Mathieson PW, Sacks SH. Expression and tissue localization of donor-specific complement C3 synthesized in human renal allografts. Eur J Immunol 1995;25:1087-93.
14. Tang S, Zhou W, Sheerin S, Vaughan RW, Sacks SH. Contribution of renal secreted complement C3 to the circulating pool in humans. J Immunol 1999;162:4336-41.
15. Soulillou JP, Giral M. Influence of graft characteristics on the outcome of kidney transplantation. N Engl J Med 2006;354: 2060-2.
16. Botto M, Fong KY, So AK, Koch C, Walport MJ. Molecular basis of polymorphisms of human complement component C3. J Exp Med 1990;172:1011-7.
17. Arvilommi H. Capacity of complement c3 phenotypes to bind on to mono- nuclear cells in man. Nature 1974;251:740-1.
18. Bartók I, Walport MJ. Comparison of the binding of C3S and C3F to complement receptors types 1, 2, and 3. J Immunol 1995;154:5367-75.